Interestingly, the serum level of HMGB1 was not different between patients with cCLD and dCLD at baseline but was significantly elevated in patients with compensated CLD developing AD during follow versus patients with stably compensated CLD (P = 0.03). The gene discussed is HMGB1; the disease is congenital secretory chloride diarrhea 1.